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By Barbara W. Grant, William L. Nichols, Lawrence A. Solberg, Diane J. Yachimiak, and Kenneth G. Mann
The isolation and characterization of human megakaryo-
cyte growth factors has been hampered because evalua-
tion of megakaryocyte growth in semisolid medium
requires both lengthy incubation and visual quantitation. In
addition. colony formation requires cell division. while most
regulation of platelet production may involve individual.
nonproliferating differentiating megakaryocytes. We have
developed a radioimmunoassay (RIA) that makes use of an
iodinated murine monoclonal antibody (MoAb) specific for
platelet/megakaryocyte glycoprotein lIb/Illa (GPIIb/llla) to
measure megakaryocyte production in liquid marrow cul-
ture. This assay is sensitive to 3 x 1 O￿ platelets (roughly 30
megakaryocytes) and linear up to 1 x 10’ platelets. and
A CCUMULATING evidence suggests that the regula-
tion of megakaryocyte production in mammals is
exerted at at least two different steps in the megakaryocyte-
platelet differentiation pathway)3 Increasingly sensitive
assays for megakaryocyte colony formation have facilitated
the study of the early (proliferative) phase of megakaryocy-
topoiesis.46 This phase of platelet production is, however, the
least sensitive to acute changes in platelet count’7’0 and thus
arguably less important in day-to-day platelet number
homeostasis. Because most of the control of platelet produc-
tion may be exerted upon single cells that ultimately become
multinucleate, expand their membrane, and mature cyto-
plasmically to produce platelets, it seems appropriate to
develop an assay that would be sensitive to megakaryocyte
maturation. In addition, colony assays for megakaryocyto-
poiesis require 1 1 to 1 5 days of incubation before colonies
(CFU-M) can be accurately counted by visual inspection.5’6
A less time-consuming and labor-intensive assay for use as a
screening test for growth factors was therefore most desir-
able.
The glycoprotein lIb/Illa (GPIIb/IIIa) complex is pres-
ent on all recognizable human megakaryocytes and platelets
from normal donors”.’2 Fluorescent antibodies against this
complex have been extremely useful as specific markers for
megakaryocytic colonies and in identification of earlier,
morphologically unrecognizable megakaryocytic cells from
both cultures and patient materials.4”’4 As Jenkins et al’5
have shown using biosynthetic labeling of isolated CFU-
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thus it provides a useful range for quantitating megakaryo-
cyte production in in vitro marrow culture. Significant
differences (threefold to fivefold) in megakaryocyte/plate-
let-specific GPlIb/Illa complex are detected between stim-
ulated and unstimulated marrow cultures by day 7,
although antigen accrual in stimulated cultures continues
through at least day 1 6. Conditions that promote mega-
karyocyte growth in semisolid medium (ie. aplastic plasma
and PHA-LCM) have also been facilitory in liquid culture.
This rapid and sensitive assay for cell-bound GPIIb/IIIa
should facilitate recognition and isolation of megakaryo-
cyte and platelet growth factors.
S 1987 by Grune & Stratton, Inc.
M-derived human megakaryocytes, the GPIIb/IIIa complex
is made by megakaryocytes but is not synthesized in detect-
able amounts by monocyte/macrophage or erythroid cob-
nies. Thus the cell-bound GPIIb/IIIa in a heterogeneous
marrow culture cell population specifically reflects mega-
karyocytic lineage cells present, whether they are platelets,
morphologicalby recognizable megakaryocytes, or early anti-
gen-bearing small round cells. Similar increases in cell
surface membrane GPIIb/lIIa would be observed in cul-
tured marrow when more small cells are present, or when a
few individual cells mature and enlarge, or with development
of both kinds of cells.
We have developed a radioimmunoassay (RIA) to detect
cell-bound GPIIb/lIIa that allows rapid quantitative assess-
ment of in vitro megakaryocytopoiesis. Because the assay is
relatively easy to perform, it should be useful in screening for
megakaryocyte growth factors. Because accumulation of
GPIIb/IlIa is associated with cytoplasmic maturation”2 as
well as with megakaryocyte proliferation, the assay ought to
detect growth factors active in the terminal events of mega-
karyocytopoiesis or platelet production, in addition to factors
that influence megakaryocyte proliferation.
MATERIALS AND METHODS
Marrow culture and cell preparation. Nucleated bone marrow
cells were obtained from normal volunteers who had given informed
consent consistent with institutional guidelines. Marrows were col-
lected into preservative-free heparin (GIBCO Laboratories, Grand
Island, NY), diluted one to three in phosphate-buffered saline
(PBS), and spun at 120 g for 15 minutes to remove platelet-rich
plasma.’6 Red blood cells (RBCs) and granulocytes were separated
from marrow mononuclear cells by density gradient separation
(Histopaque-1077, Sigma Diagnostics, St. Louis), and another slow
spin was done. Adherent cells and additional platelets were depleted
by incubation of mononuclear cells for 60 minutes in 10% fetal calf
serum in plastic flasks. Assessment of residual platelet/megakaryo-
cyte lineage cells during marrow preparation using the RIA
described below reveals 30% to 40% depletion of antigen by each
slow spin. Thus I 5% to 20% of starting activity remained before
adherance, 5% to 10% more antigen was removed by the adherence
step, and plated cells cultured contained about 10% of starting
cell-bound GPIIb/IlIa.
Marrow culture was performed in 24-well tissue culture plates
(GIBCO), at 37#{176}C, 5% CO2, and humidified atmosphere. Three to
5 x l0￿ nonadherent, light-density bone marrow cells were cultured
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Fig 1 . Binding of ‘2￿I-HP1 -1 D to fresh human platelets. Data
shown are the mean of triplicates. Very similar curves were
obtained using platelets from different donors or commercially
obtained lyophilized platelets.
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in Iscove’s modified Dulbecco’s medium (GIBCO) supplemented
with 30% serum or plasma, 5 x IO￿ mol/L 2-mercaptoethanol, and
growth factors as noted, in 1 mL final volume. Plasma and serum
samples were obtained from consenting normal volunteers and were
filtered through 0.2-z filters prior to use in cultures. Plasmas were
prepared from blood drawn into syringes containing preservative-
free heparin. Aplastic plasma was the gift of H. Messner, Toronto,
Ontario, and fetal bovine serum (FBS) was purchased (Hycbone
Laboratories, Logan, UI). PHA-LCM was prepared as previously
described. ‘￿
Human umbilical vein endothelial cells cultured to confluence
over five days as previously described’8 were kindly provided by i.
Hoak. After detachment from flasks by a 0.02% EDTA rinse
followed by incubation in 0.5% Irypsin (five minutes, 37#{176}C),
endothelial cells were washed, counted, and assayed by R1A as
above.
Megakaryocytes were quantitated in individual wells by counting
nonadherent cells using a hemacytometer and multiplying by the
percentage of recognizable megakaryocytes found on a stained
cytocentrifuge preparation ( I ,500 cell differentials).
Radioimmunoassay HP1-l D is a murine antihuman glycopro-
tein bIb/lIla complex monoclonal antibody (MoAb) of lgG25 iso-
type.’3’5 The antibody is specific for human platelet or megakaryo-
cyte GPIIb/llla, and does not recognize cells of other blood or
marrow cell ￿ lgG was isolated from the ascites by
protein A-Sepharose’9 (Sigma) and iodinated using lodogen-treated
tubes (PierceChemical Co, Rockford, IL) and Iodine-125 (1251; New
England Nuclear, Boston). Platelets were isolated using the Mus-
tard technique’6 or were obtained in lyophilized form (Bio/Data,
Hatboro, PA). The binding of 1251 HPI-1D to platelets and cultured
marrow was examined in phosphate-buffered saline (PBS) contain-
ing 20% bovine calf serum to block nonspecific and F￿ binding and
0.002% EDTA to prevent clumping. After 30 to 60 minutes of
incubation, binding was complete at 4#{176}C and at 22#{176}C, and subse-
quent RIAs were routinely performed at 4#{176}C with one-hour incuba-
tion. On several occasions, however, we did observe small (< 15% of
total counts bound) increases in ‘251-HP1-l D bound between 60 and
180 minutes both to fresh platelets and to cultured marrow. This
may have been due to slow access of antibody to antigen in the
canalicular system or to possible antigen exposure due to platelet
swelling in EDTA. No slow, late increase in binding was observed
when marrow cultured 12 days in FCS alone was assayed (the
differential included 20% macrophages, <0.1% megakaryocytes). It
is possible that by choosing one-hour incubations we did not always
maximize binding to platelet lineage cells; however, all tubes for a
given assay were stopped within a minute or two of each other (by
dilution with cold carrier cells and centrifugation) so that compari-
sons of binding within sets of tubes are valid.
For the routine assay, bone marrow cells or platelets were
suspended in assay buffer (20% heat-inactivated bovine calf serum,
0.002% EDIA in PBS), pelleted, and supernate decanted. The pellet
was resuspended in 100 ￿iL chilled assay buffer and 100 jzL of
iodinated HPI-1D in chilled 0.1 mol/L sodium phosphate buffer,
pH 7.4; 1% FBS was added (usually 400,000 cpm or approximately
0.02 ￿tg antibody). The mixture was incubated at 4#{176}C with intermit-
tent shaking for 60 minutes, following which 800 ￿.tL chilled buffer
containing 4 x 106 GPIIb/IIIa-negative carrier cells (usually Jurkat
T-Iymphoblastoid cells) were added and mixed. After pelleting, the
supernate was aspirated, the cells washed once in 1-mL assay buffer,
and the pellets counted with a gamma counter. For competition
assays, cold antibody was incubated with target cells for 30 minutes
at 4#{176}C prior to addition of ‘251-HPI-l D. Control MoAbs included
anti-TAC, which is specific for interleukin 2 (lL2) receptors (the
gift of T. Waldmann), and a-PS, which is specific for the coagula-
tion protein S (the gift of W. Church). Assays from marrow cultures
were done in duplicate or triplicate on 20O-￿L aliquots of resus-
pended cells from each well.
Autoradiography. Cells for autoradiography were labeled with
‘251-HPI-ID, as described in the section above, but subjected to one
additional wash. Suspended samples were then centrifuged onto
clean glass slides by cytocentrifuge, dipped in photographic emulsion
(NTB-2, Kodak, Rochester, NY), and developed for approximately
two days at 4#{176}C. Following development with D-19 (Kodak), the
slides were equilibrated with buffer and stained with Wright’s
stain.
RESULTS
The RIA, as developed using iodinated HPI - I D, can
detect as few as 3 x 10￿ platelets and is linear between I 0￿
and 106 platelets (Figs 1 and 2). This latter level coincides
with calculated antigen excess, if one assumes 40,000 glyco-
protein llb/Illa complexes per platelet.2#{176} Four separate
antibody iodinations and over 50 platelet titrations have
yielded completely reproducible results. Approximately 0.02
lLg of antibody and 400,000 counts per minute are added to
each assay tube. If the average megakaryocyte has approxi-
mately 100 times the surface area ofa platelet,*22 this assay
can detect accurately between 100 and 10,000 megakaryo-
cytes per abiquot.
The specificity of iodinated HP1-bD binding to platelets
was ascertained by competition experiments using cold HPI-
1D, a murine lgG monoclonal nonreactive with platelets
(anti-TAC), and murine polyclonab IgG (Fig 2). Binding of
labeled antibody was competitively blocked by increasing
concentrations of cold HPI-bD but not by either of the
nonspecific antibody preparations. Competition experiments
using cultured (day 14) marrow cells similarly demonstrated
blocking by cold HPI-lD but not by another murine mono-
cbonal of the same isotype (cr-PS is specific for the coagula-
tion protein S and does react with human platelets; Table 1).
*Ihe formula for the surface area of a sphere is ir d2. Given an
average platelet diameter of 3 iz, and an average megakaryocyte
diameter of 30 ￿2I a ratio of platelet surface area to megakaryocyte
I
C)
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Fig 2. Binding of ‘21-HP1-1D to platelets (O--O) is not
influenced by pre-incubation of platelets with nonspecific anti-
bodies (1 .0 iLg a-TAC. #{149}-#{149};1 .0 ￿g murine ‘y globulin. U--U).
Increasing amounts of cold HP1 -1 D progressively inhibit binding of
the iodinated antibody (0.0075 sg HP1 -1 D. A-A; 0.01 5 ￿sg
HP1-1D. EJ----D; 0.03 gig HP1-1D. #{149}-#{149}-#{149}; 0.06 M9 HP1-1D.
U---U; 0.12 pg HP1-1D. ￿---￿J.
bodinated HPI-lDdid not bind tocultured human umbilical
vein endothelial cells, with counts bound in a titration from
b0￿ to 106 cells being equivalent to that of the Jurkat
T-Iymphoblastoid control (<500 cpm). To be sure that
trypsin and EDTA used to remove adherent endothelial cells
from flasks before the RIA had not destroyed endotheliab cell
GPIIb/lIIa, platelets were subjected to similar treatment.
EDTA-trypsin treatment of platelets caused only a 20% to
30% decrease in binding of ‘251-HP1-1D.
Human light density nonadherent bone marrow cells grow
well in liquid culture, with formation of recognizable
erythroblasts, macrophages, granulocytes, and megakaryo-
cytes depending on the growth conditions. Using the RIA we
monitored total cell-bound GPIIb/IIIa present on marrow
cells cultured over 15 days in various conditions. The results
of a representative experiment are depicted in Fig 3 and
Table 2 gives summary data. During the first four to seven
days in culture, cell-bound GPIIb/IIIa falls, presumably as
residual platelets in the marrow preparation disintegrate,
adhere to the plates, or are ingested by other cells. Culture of
marrow in media supplemented with fetal bovine serum
(FBS) by itself permitted minimal antigen accrual over 2
weeks time. However, FBS reproducibly supported a
response to PHA-LCM that was usually significant by day 7
Table 1 . Binding of ‘35l-HP1 -1 D to Cultured Bone Marrow Cells is
Blocked by Cold HP1 -1 D but not by Another Murine lgG,￿
Monoclonal. a-PS
Fig 3. Megakaryocytopoiesis in liquid cultures supplemented
by (A) fetal bovine serum or (B) aplastic human plasma. as
measured by cell-bound ￿1-HP1 -1 D. Five hundred thousand mar-
row cells per well were cultured with or without PHA-ICM for
￿ varied numbers of days in this representative experiment.
in culture and always two to four times that of FBS alone by
day 14. Aplastic human plasma routinely supported the
formation of cell-bound glycoprotein IIb/IIIa complex by
day 7. Antigen accrual continued through day 15 and was
markedly stimulated by the addition of PHA-LCM. Thus
although the assay detects a significant difference between
marrow cultured in FBS alone and that cultured in aplastic
plasma with PHA-LCM by day 7 (mean of fourfold differ-
ence), by day 14 this difference is far larger (mean of
30-fold, Table 2).
We found that bone marrow cells cultured with 30%
normal human plasma or serum had little cell-bound glyco-
protein Ilb/IIIa after two weeks in culture (Fig 4). The
addition of PHA-LCM to these cultures had variable effects,
with some normal samples allowing an increment of twofold
or threefold antigen increase over two weeks time, but with
the majority of normal plasmas and sera not supporting such
megakaryocyte growth (Fig 4). For a given donor, plasma
and serum usually had similar growth supporting character-
istics (the plasma and serum samples in Fig 4 are from the
same donors).
The RIA proved very reliable in measuring megakaryo-
cyte lineage cells in liquid culture in over 40 experiments
using different bone marrow samples. Microscopic examina-
tion of cytospins from the cultures after day 5 revealed
recognizable megakaryocytes proportionate to bound counts
(Fig 5). The standard error between aliquots from a given
well (duplicates or triplicates) ranged from 0% to 10% of the
mean counts bound and was usually less than 5%. Well-
to-well variation (ie, duplicate wells set up on day I and
compared on the day of assay) was occasionally somewhat
greater, but statistically significant differences between
unstimubated and stimulated wells (for instance fetal bovine
serum with and without PHA-LCM) were present by day 1 1
even in the most unresponsive marrow. Radioimmunoassays
were routinely performed only on easily resuspendable cells;
however, when adherent cells were removed with a rubber
policeman and assayed, no counts above background were
observed.
Visualization of the populations of cells binding iodinated
HP1-ID was performed using autoradiography on the cub-
tured marrow populations (Fig 6). Activity bound to recog-
Competing Antibody CPM Bound ± SEM
None 4221 ± 83.4
HP1-1D (1 Mg) 612 ± 55.2
a-PS(1￿g) 4559.5 ± 73.9
Target cells were aliquots of marrow cells ( 1O￿ cells/aliquot) that had
been cultured 14 days in 30% FCS + 5% PHA-LCM. Cells were reacted
30 minutes at 22 ‘ C with competing antibody prior to addition of
‘25l-HP 1-iD.
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Fig 4. Megakaryocytopoiesis in liquid cultures supplemented
by normal human plasma or serum as measured by cell-bound
￿l-HP1 -1 D. Three hundred thousand marrow cells per well were
cultured with or without added PHA-LCM two weeks prior to
assay. (A). Normal human plasma; (B). normal human serum.
6000
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Table 2. Compilation of GPllb/llla Radioimmunoassay Results From M arrow Cultured 7. 10. or 14 Days Under Different Conditions
Culture Conditions
Days in Cultt.a-e
7 10 14
FBS alone
FBS + PHA-LCM
Aplasticplasma
Aplastic plasma
+ PHA-LCM
100 (9)
184 ± 14.7 (9)
272 ± 35(9)
400 ± 58.3 (8)
74.5 ± 10.3 (6)
489 ± 121 (6)
640 ± 136(9)
1095 ± 155.8 (8)
68 ± 7.6 (4)
490 ± 134 (4)
1106 ± 169(7)
2318 ± 358 (6)
Results for each marrow were expressed relative to the counts bound by cells cultured seven days in FBS alone for that marrow prior to averaging. For
each mean percentage, the standard error of the mean is given, with ‘n’ ‘ in parentheses.
nizable megakaryocytes in all stages of maturation and, in
addition, was found on rare, small round cells similar to those
found in megakaryocyte colonies.5”2 Activity was not found
on monocytes, macrophages, granubocytes, or erythroblasts.
DISCUSSION
We have developed an accurate, specific, and rapid screen-
ing RIA for cell-bound GPIIb/IIIa that is useful for the
quantitation of human megakaryocytes grown in liquid mar-
row culture. GPIIb/lIIa on the surface ofcells is quantitated
by use of an iodinated MoAb specific for the human platelet
or megakaryocyte GPIIb/IIla complex. Bound antibody is
separated from free antibody by centrifugation of cells and
the pellet counted in a gamma counter.
The presence of the GPIIb/IlIa complex on megakaryo-
cytic lineage cells ranging from small round morphologically
undifferentiated cells to recognizable mature megakaryo-
cytes and platelets has been well described”2 and the
complex has been used by many investigators as a target for
immunofluorescent probes in characterizing cells from cob-
nies.4”’3’23 Some investigators have questioned the specific-
ity ofGPIIb/IIIa to the megakaryocytic lineage, however, as
similar proteins cross-reactive with certain antibodies made
against GPIIb/IIIa or GPIIIa have been described in mono-
cyte, endothebial, smooth muscle and fibroblast-bike cell
preparations.2428 It is likely that shared antigens in the
a-chain of a family of similar membrane glycoprotein com-
plexes explain this cross-reactivity.28
HPI-1D antibody appears to be specific for the GPIIb/
lila complex rather than for one of the two glycoproteins, as
dissociation of the complex by incubation of platelets with
EDTA at 37#{176}C29 reduces HPI-1D binding to platelets, and
the antibody does not specifically bind to ebectrophoretically
separated GPIlb and GPIIIa in Western blots (Nichols,
unpublished data). We have not found cross-reactivity of
HPI-l D with antigens or cells from outside the human
megakaryocyte/platebet lineage.’3”5’22 In the present study
we examined cell types found in marrow cultures and found
no evidence that ‘25I-HPI-1D bound to monocytes, macro-
phages, endothebiab cells, or fibroblasts (by RIA, autoradi-
ography, or both). We have previously reported the biosyn-
thesis of GPIIb/llla by megakaryocyte colonies (CFU-M)
plucked from methylcellubose marrow ￿ In those
studies our monocbonal against the human GPIIb/IIIa com-
plex, HP1-lD, was used to purify the 35S-methionine-babeled
complex from cell bysates, and no detectable GPIIb/IIIa was
synthesized by monocyte/macrophage colonies. Thus to the
best of our knowledge HPI-1D antibody is specific to the
cells of interest in this investigation.
The sensitivity of the RIA is probably similar to that of
colony assays, but since very different products are measured
in the different assays, this comparison must be only a
general one. Investigators report megakaryocyte colony sizes
ranging from three to 500 cells, with mean colony size less
__I￿ _￿_1 _- I I I
4000
Numbr of Megakaryocytes per 200￿U Aliquot
Fig 5. Counts bound are proportionate to recognizable mega-
karyocytes after 12 days in various liquid culture conditions
(r = 0.97). Megakaryocytes per fraction were determined by mul-
tiplying the number of cells per aliquot (as determined by hemacy-
tometer count) by the percentage of megakaryocytes in a differen-
tial of 1.500 cells done on a cytospin from that well. Percentages
varied in this representative experiment from 0% to 3%.
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Fig 6. Autoradiographic demonstration of the specificity of
￿1-HP1 -1 D binding to cells. Many grains are seen over the Stage Ill
megakaryocyte. while few are seen over an adjacent macrophage.
(Original magnification x 1 .000. current magnification x 680.)
than 100 cells.’” No colonies are routinely formed in unsti-
mulated (normal human plasma) cultures, whereas aplastic
plasma and Pl-IA-LCM permit up to 50 colonies per l0￿
marrow cells.46’23 In unstimulated liquid cultures we find 500
to 1,200 CPM bound, which corresponds to about I to 2 x
l0￿ platelets or 10 to 20 megakaryocytes. Mature mega-
karyocytes are found on cytospin preparations of these
cultures, implying that some individual cells may mature in
vitro to megakaryocytes under conditions where no colonies
are formed. Marrow cultured in aplastic plasma and PHA-
LCM binds 4,000 to 30,000 CPM per 10￿ starting cells by
day I 4, which by extrapolation from platelet-binding curves
corresponds to I ,000 to 10,000 megakaryocytes. We stress
that although these calculations demonstrate that colony
assays and liquid marrow culture assayed by RIA detect
about the same amount of megakaryocyte growth from
human marrow preparations, the product measured is very
different. The unit of measure in a colony assay is the colony
that represents proliferative and differentiative changes
occurring among the progeny of one stem cell over time in
culture. On the other hand, in the RIA the unit of measure is
a GPIIb/IIla complex expressed on the surface of a cell
where it can bind radiolabeled antibody. Cells binding
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day 14 to 16. Statistically significant differences between
stimulated and unstimubated liquid culture wells are
detected by the RIA as soon as days 5 to 7, although in liquid
culture also antigen accrual continues through day I 5.
The formation of megakaryocyte colonies in semisolid
medium by definition requires that the committed cells
undergo cell division, while much of the regulation of mega-
karyocyte maturation and platelet shedding probably occurs
on cells that undergo few if any further cell divisions. Thus,
colony assays, while sensitive for factors that promote or
permit proliferation (colony stimulating factors), may not
detect regulators of megakaryocyte maturation (megakaryo-
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